Alyeska Investment Group
AMRX icon

Alyeska Investment Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Alyeska Investment Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-267,475
Closed -$1.92M – 402
2019
Q2 		$1.92M Sell
267,475
-127,881
-32% -$1.31M 0.03% 323
2019
Q1 		$5.6M Buy
395,356
+153,112
+63% +$2.02M 0.08% 216
2018
Q4 		$3.28M Sell
242,244
-383,178
-61% -$6.9M 0.05% 256
2018
Q3 		$13.9M Buy
625,422
+447,982
+252% +$9.43M 0.16% 158
2018
Q2 		$2.91M Buy
+177,440
New +$3.11M 0.03% 325

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM